Literature DB >> 20724543

Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia.

Lubica Rauova1, Jessica D Hirsch, Teshell K Greene, Li Zhai, Vincent M Hayes, M Anna Kowalska, Douglas B Cines, Mortimer Poncz.   

Abstract

Heparin-induced thrombocytopenia (HIT) is a life- and limb-threatening thrombotic disorder that develops after exposure to heparin, often in the setting of inflammation. We have shown previously that HIT is associated with antibodies to complexes that form between platelet factor 4 and glycosaminoglycan (GAG) side chains on the surface of platelets. However, thrombosis can occur in the absence of thrombocytopenia. We now show that platelet factor 4 binds to monocytes and forms antigenic complexes with their surface GAG side chains more efficiently than on platelets likely due to differences in GAG composition. Binding to monocytes is enhanced when the cells are activated by endotoxin. Monocyte accumulation within developing arteriolar thrombi was visualized by situ microscopy. Monocyte depletion or inactivation in vivo attenuates thrombus formation induced by photochemical injury of the carotid artery in a modified murine model of HIT while paradoxically exacerbating thrombocytopenia. These studies demonstrate a previously unappreciated role for monocytes in the pathogenesis of arterial thrombosis in HIT and suggest that therapies targeting these cells might provide an alternative approach to help limit thrombosis in this and possibly other thrombotic disorders that occur in the setting of inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20724543      PMCID: PMC3012595          DOI: 10.1182/blood-2010-03-276964

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients.

Authors:  Andreas Greinacher; Beate Farner; Hartmut Kroll; Thomas Kohlmann; Theodore E Warkentin; Petra Eichler
Journal:  Thromb Haemost       Date:  2005-07       Impact factor: 5.249

2.  Cell surface proteoglycan expression during maturation of human monocytes-derived dendritic cells and macrophages.

Authors:  Y Wegrowski; A-L Milard; G Kotlarz; E Toulmonde; F-X Maquart; J Bernard
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

3.  Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.

Authors:  Lubica Rauova; Li Zhai; M Anna Kowalska; Gowthami M Arepally; Douglas B Cines; Mortimer Poncz
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

Review 4.  Endothelial cells in physiology and in the pathophysiology of vascular disorders.

Authors:  D B Cines; E S Pollak; C A Buck; J Loscalzo; G A Zimmerman; R P McEver; J S Pober; T M Wick; B A Konkle; B S Schwartz; E S Barnathan; K R McCrae; B A Hug; A M Schmidt; D M Stern
Journal:  Blood       Date:  1998-05-15       Impact factor: 22.113

5.  The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model.

Authors:  S E McKenzie; S M Taylor; P Malladi; H Yuhan; D L Cassel; P Chien; E Schwartz; A D Schreiber; S Surrey; M P Reilly
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

6.  Regulated expression of platelet factor 4 in human monocytes--role of PARs as a quantitatively important monocyte activation pathway.

Authors:  Andreas Schaffner; Petra Rhyn; Gabriela Schoedon; Dominik J Schaer
Journal:  J Leukoc Biol       Date:  2005-03-23       Impact factor: 4.962

7.  Polymorphonuclear leukocyte and monocyte activation induced by plasma from patients with heparin-induced thrombocytopenia in whole blood.

Authors:  Mahnouch Khairy; Dominique Lasne; Aymeric Amelot; Malvina Crespin; Francine Rendu; Martine Aiach; Christilla Bachelot-Loza
Journal:  Thromb Haemost       Date:  2004-12       Impact factor: 5.249

Review 8.  Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.

Authors:  Douglas B Cines; Lubica Rauova; Gowthami Arepally; Michael P Reilly; Steven E McKenzie; Bruce S Sachais; Mortimer Poncz
Journal:  J Clin Apher       Date:  2007-02       Impact factor: 2.821

9.  Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin.

Authors:  Don E Eslin; Chunyan Zhang; Kathleen J Samuels; Lubica Rauova; Li Zhai; Stefan Niewiarowski; Douglas B Cines; Mortimer Poncz; M Anna Kowalska
Journal:  Blood       Date:  2004-02-05       Impact factor: 22.113

10.  Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia.

Authors:  Lubica Rauova; Mortimer Poncz; Steven E McKenzie; Michael P Reilly; Gowthami Arepally; John W Weisel; Chandrasekaran Nagaswami; Douglas B Cines; Bruce S Sachais
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

View more
  52 in total

1.  Refractoriness to platelet transfusion in acute myeloid leukemia correlated with the optical density of anti-platelet factor 4/heparin antibodies.

Authors:  Mizuki Aimoto; Takahisa Yamane; Kazumasa Shiomoto; Chikahiko Sakamoto; Yasuhiro Nakashima; Hideo Koh; Takahiko Nakane; Yasunobu Takeoka; Asao Hirose; Mika Nakamae; Kiyoyuki Hagihara; Yoshiki Terada; Yoshitaka Nakao; Hirohisa Nakamae; Masayuki Hino; Shigeki Miyata
Journal:  Int J Hematol       Date:  2013-10       Impact factor: 2.490

2.  Neutrophil accumulation and NET release contribute to thrombosis in HIT.

Authors:  Kandace Gollomp; Minna Kim; Ian Johnston; Vincent Hayes; John Welsh; Gowthami M Arepally; Mark Kahn; Michele P Lambert; Adam Cuker; Douglas B Cines; Lubica Rauova; M Anna Kowalska; Mortimer Poncz
Journal:  JCI Insight       Date:  2018-09-20

3.  Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia.

Authors:  Valerie Tutwiler; Daria Madeeva; Hyun Sook Ahn; Izabella Andrianova; Vincent Hayes; X Long Zheng; Douglas B Cines; Steven E McKenzie; Mortimer Poncz; Lubica Rauova
Journal:  Blood       Date:  2015-10-30       Impact factor: 22.113

Review 4.  Microparticles in hemostasis and thrombosis.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Circ Res       Date:  2011-05-13       Impact factor: 17.367

5.  Acute oxygenator failure: a new presentation of heparin-induced thrombocytopenia in a patient undergoing venovenous extracorporeal membrane oxygenation support.

Authors:  Robert A Ratzlaff; Juan G Ripoll; Lena L Kassab; Jose L Diaz-Gomez
Journal:  BMJ Case Rep       Date:  2016-12-16

Review 6.  Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.

Authors:  Daniela R Junqueira; Liliane M Zorzela; Edson Perini
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

Review 7.  Diagnosis and management of heparin-induced thrombocytopenia.

Authors:  Grace M Lee; Gowthami M Arepally
Journal:  Hematol Oncol Clin North Am       Date:  2013-04-13       Impact factor: 3.722

8.  Novel diagnostic assays for heparin-induced thrombocytopenia.

Authors:  Adam Cuker; Ann H Rux; Jillian L Hinds; May Dela Cruz; Serge V Yarovoi; Isola A M Brown; Wei Yang; Barbara A Konkle; Gowthami M Arepally; Stephen P Watson; Douglas B Cines; Bruce S Sachais
Journal:  Blood       Date:  2013-02-27       Impact factor: 22.113

Review 9.  Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia.

Authors:  Steven E McKenzie; Bruce S Sachais
Journal:  Curr Opin Hematol       Date:  2014-09       Impact factor: 3.284

Review 10.  Atomic features of an autoantigen in heparin-induced thrombocytopenia (HIT).

Authors:  Zheng Cai; Zhiqiang Zhu; Mark I Greene; Douglas B Cines
Journal:  Autoimmun Rev       Date:  2016-03-09       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.